Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Ypsilanti MI, Peoria IL, York PA, Washington DC DC,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Ann Arbor MI, Grand Rapids MI, Centerville OH,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ultra Crave: An Investigation of Ultra-Processed Food
for
Food Addiction
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 22 - 60
Code: NCT06044285
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Ann Arbor MI, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase3, Recruiting
BoxX-NoAF Clinical Trial
for
Post Operative Atrial Fibrillation,
Location: Ypsilanti MI, London, Cleveland OH, Grand Rapids MI,
Sponsor: AtriCure, Inc.
Sex: All
Age: 65+
Code: NCT06989775
Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Ypsilanti MI, Springfield OH, Cincinnati OH,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Ypsilanti MI, Ann Arbor MI, Fort Wayne IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Ann Arbor MI, Goshen IN, Cincinnati OH, La Crosse WI,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT07211178
Recruiting
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
for
Cardiovascular Diseases
Location: Ypsilanti MI, Asheville NC
Sponsor: Pritikin ICR
Sex: All
Age: 18+
Code: NCT06424119
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: Detroit MI, Ann Arbor MI, London, Cleveland OH,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
for
Pulmonary Embolism
Location: Ypsilanti MI, Ann Arbor MI, Toledo OH, Pittsburgh PA,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT05591118
Phase3, Recruiting
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
for
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Ypsilanti MI, Cleveland OH, Hinsdale IL, Hershey PA,
Sponsor: SynDevRx, Inc.
Sex: All
Age: 18+
Code: NCT05455619
Phase1, Phase2, Recruiting
EXPAREL Post-tonsillectomy Clinical Trial
for
Tonsillectomy
Location: Ypsilanti MI, Ann Arbor MI
Sponsor: Paul Hoff
Sex: All
Age: 18+
Code: NCT03420638
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease